Emerge is transparent about its tiers and names its pharmacies, but gets pricier as you climb. No membership fee, a clear dose ladder starting at about $287/mo (2.5 mg), and named partner pharmacies (Empower, Hallandale, Strive, Alchemist) are real positives. But the cost rises with your dose to about $419/mo at 15 mg, it is tirzepatide-only (semaglutide is not publicly offered), and the review base is small.
Emerge at a glance
- Category:
- Telehealth weight-loss (GLP-1)
- Medication:
- Compounded tirzepatide only (not FDA-approved); semaglutide not publicly offered
- Tirzepatide:
- Dose-tiered ~$287/mo at 2.5 mg up to ~$419/mo at 15 mg
- Semaglutide:
- Not publicly offered (verify)
- Membership fee:
- None
- Dose impact:
- Cost rises with dose (~$132/mo more at 15 mg vs 2.5 mg)
- Pharmacy:
- Names partners: Empower, Hallandale, Strive, Alchemist (per-order disclosure verify)
- States:
- 49 states (excludes California; verify)
- Reviews:
- Rating pending verification
- Clinical model:
- Short form + self-recorded video; no live telehealth visit required
- Regulatory note:
- None identified as of June 2026; verify
Pros and cons
What we like
- Names multiple partner pharmacies (Empower, Hallandale, Strive, Alchemist)
- No membership fee; low entry-dose price ($287/mo at 2.5 mg)
- Transparent, published dose tiers
- Fast, low-friction onboarding; 49 states
Trade-offs to know
- Cost rises with dose — up to ~$419/mo at 15 mg
- Tirzepatide-only — semaglutide is not publicly offered
- No live clinical visit (short form + self-recorded video)
- Not available in California
- Small, unverified review base
- Medication is compounded — not FDA-approved
Scorecard
Scored on the same five-criterion rubric we apply to every provider. Weights in parentheses.
Pricing: transparent, but rises with dose
Emerge uses dose-tiered pricing for compounded tirzepatide with no membership fee: roughly $287/mo at the 2.5 mg dose rising to about $419/mo at 15 mg. In practice, a 15 mg patient pays about $132 more per month than a 2.5 mg patient, so your bill climbs as your dose does. The tiers are published, which is a transparency positive. Emerge is tirzepatide-focused and does not publicly offer semaglutide (verify). If you'll stay at a low dose, the entry price is attractive; if you titrate up, budget for the higher tiers.
Pharmacy & sourcing
Emerge names partner compounding pharmacies — Empower, Hallandale, Strive, and Alchemist — though it may not disclose which one fills a given order (verify). Because compounded drugs are not FDA-approved, naming the pharmacy partners is a transparency plus that lets patients check each pharmacy's licensing and accreditation, even if per-order disclosure is limited. This lifts Emerge's pharmacy-disclosure score relative to peers that name no pharmacy at all.
Reviews & reputation
We have not verified Emerge's third-party rating to a primary source, so we show its rating as pending verification rather than publish an unconfirmed number. Emerge has a limited review base, so individual experiences carry more weight and averages can move quickly — check current listings before deciding.
Regulatory context
We identified no regulatory actions or lawsuits involving Emerge as of June 2026; verify current dockets and listings. We note this because regulatory posture is part of our rubric; the absence of identified issues is presented factually, not as an endorsement.
Who Emerge is best for
Choose Emerge if you want tirzepatide with no membership fee, value a provider that names its pharmacy partners, and expect to stay at a lower dose where the entry price is low. Consider our #1 pick instead if you want a price that does not rise with your dose, a semaglutide option (Emerge is tirzepatide-only), and coverage in all 50 states (Emerge excludes California) — see our MaxLife review.
Emerge FAQ
How much does Emerge really cost?
Emerge uses dose-tiered pricing for compounded tirzepatide with no membership fee: roughly $287/mo at the 2.5 mg dose rising to about $419/mo at 15 mg, so a 15 mg patient pays about $132 more per month than a 2.5 mg patient. Emerge is tirzepatide-focused and does not publicly offer semaglutide; verify before deciding.
Does Emerge name its compounding pharmacy?
Yes. Emerge names partner compounding pharmacies including Empower, Hallandale, Strive, and Alchemist, though which one fills a given order may not be disclosed per order (verify). Because compounded drugs are not FDA-approved, naming the pharmacy partners is a transparency plus that lets patients check licensing and accreditation.
Is Emerge FDA-approved?
Emerge's compounded tirzepatide and semaglutide are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. Compounded tirzepatide is not Mounjaro® or Zepbound®; compounded semaglutide is not Ozempic® or Wegovy®.